Cloud-clone
SKU(재고 관리 코드):PAA061Rb52
Polyclonal Antibody to Interleukin 15 (IL15)
Polyclonal Antibody to Interleukin 15 (IL15)
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.
Product No.
PAA061Rb52
Organism Species
Oryctolagus cuniculus (Rabbit).
Source
Polyclonal antibody preparation
Host
Guinea pig
Potency
n/a
Ig Type
IgG
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Label
APC
Immunogen
n/a
Buffer Formulation
PBS, pH7.4, containing 0.02% NaN3, 50% glycerol.
Traits
Liquid
Concentration
500µg/mL
Organism Species More
n/a
Applications
WB; IHC; ICC; IP.
If the antibody is used in flow cytometry, please check FCM antibodies.
UOM
20µl 100µl 200µl 1ml 10ml
SPECIFITY
The antibody is a cavia polyclonal antibody raised against IL15. It has been selected for its ability to recognize IL15 in immunohistochemical staining and western blotting.
USAGE
Western blotting: 0.2-2µg/mL;1:250-2500
Immunohistochemistry: 5-20µg/mL;1:25-100
Immunocytochemistry: 5-20µg/mL;1:25-100
Optimal working dilutions must be determined by end user.
STORAGE
Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
STABILITY
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
| Magazine | Citations |
| Endocrine | Expression of interleukin-15 and inflammatory cytokines in skeletal muscles of STZ-induced diabetic rats: effect of resistance exercise training Pubmed: 24006180 |
| Endocrine | Time course of IL-15 expression after acute resistance exercise in trained rats: effect of diabetes and skeletal muscle phenotype Pubmed:25522723 |
| Med Sci Moni | miR-15b is Downregulated in Myasthenia Gravis Patients and Directly Regulates the Expression of Interleukin-15 (IL-15) in Experimental Myasthenia Gravis Mice PubMed: 26087886 |
| Exercise physiology | Effects of intrinsic aerobic capacity, aging and physical activity on interleukin-15 protein level in serum and skeletal muscle Dspace: Handle |
| Biotechnology Letters | Novel adjuvant for immunization against tuberculosis: DNA vaccine expressing Mycobacterium tuberculosis antigen 85A and interleukin-15 fusion product elicits strong immune responses in mice s10529-017-2342-1 |
| Journal of Controlled Release | Interleukin-15 and cisplatin co-encapsulated thermosensitive polypeptide hydrogels for combined immuno-chemotherapy. pubmed:28408199 |
| Catalog No. | Related products for research use of Oryctolagus cuniculus (Rabbit) Organism species | Applications (RESEARCH USE ONLY!) |
| RPA061Rb01 | Recombinant Interleukin 15 (IL15) | Positive Control; Immunogen; SDS-PAGE; WB. |
| PAA061Rb51 | Polyclonal Antibody to Interleukin 15 (IL15) | WB; IHC; ICC; IP. |
| PAA061Rb01 | Polyclonal Antibody to Interleukin 15 (IL15) | WB; IHC; ICC; IP. |
| PAA061Rb52 | Polyclonal Antibody to Interleukin 15 (IL15) | WB; IHC; ICC; IP. |
Share
